Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$1.21B |
| 2 |
Sea Limited
SE
|
+$842M |
| 3 |
Okta
OKTA
|
+$819M |
| 4 |
XYZ
Block Inc
XYZ
|
+$749M |
| 5 |
Mercado Libre
MELI
|
+$656M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$929M |
| 2 |
Union Pacific
UNP
|
+$677M |
| 3 |
Spotify
SPOT
|
+$575M |
| 4 |
RingCentral
RNG
|
+$499M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.98% |
| 2 | Consumer Discretionary | 23.1% |
| 3 | Communication Services | 15.59% |
| 4 | Healthcare | 8.54% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Philip Morris
PM
$291B
| $15.4M | 0.01% |
162,812
+82,456
| +103% | +$8.29M |
|
402
ProQR Therapeutics
PRQR
$258M
| $15.4M | 0.01% |
1,841,578
-758,849
| -29% | -$4.96M |
|
|
MMP
403
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $15.3M | 0.01% |
335,820
-3,286
| -1% | -$156K |
|
|
EXAS
404
DELISTED
Exact Sciences
EXAS
| $15.2M | 0.01% |
159,731
-111,634
| -41% | -$11.8M |
|
405
On Holding
ONON
$12.5B
| $15.2M | 0.01% |
+503,858
| New | +$17.7M |
|
406
Norfolk Southern
NSC
$76.7B
| $14.7M | 0.01% |
61,349
-52,893
| -46% | -$13.6M |
|
407
Newmont
NEM
$103B
| $14.6M | 0.01% |
268,068
-63,567
| -19% | -$3.75M |
|
408
NeoGenomics
NEO
$2.09B
| $14.5M | 0.01% |
301,226
-162,018
| -35% | -$7.5M |
|
409
Sysco
SYY
$39.6B
| $14.5M | 0.01% |
184,116
-5,225
| -3% | -$399K |
|
410
Diageo
DEO
$48.8B
| $14M | 0.01% |
72,437
+11,155
| +18% | +$2.16M |
|
|
CWAN
411
DELISTED
Clearwater Analytics
CWAN
| $13.9M | 0.01% |
+544,434
| New | +$14M |
|
|
AMK
412
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $13.8M | 0.01% |
555,443
-1,388
| -0.2% | -$35.8K |
|
413
10x Genomics
TXG
$6.08B
| $13.8M | 0.01% |
94,450
-235,170
| -71% | -$40.4M |
|
414
Intapp
INTA
$2.53B
| $13.7M | 0.01% |
532,271
+57,271
| +12% | +$1.86M |
|
415
Jazz Pharmaceuticals
JAZZ
$16.4B
| $13.7M | 0.01% |
105,190
-240,716
| -70% | -$36.4M |
|
416
HealthEquity
HQY
$8.78B
| $13.4M | 0.01% |
206,386
-4,512
| -2% | -$313K |
|
417
Definitive Healthcare
DH
$73.9M
| $13.3M | 0.01% |
+311,481
| New | +$13.8M |
|
418
Arvinas
ARVN
$581M
| $13.3M | 0.01% |
161,584
-2,051
| -1% | -$181K |
|
419
Freshworks
FRSH
$3.33B
| $13.3M | 0.01% |
+310,998
| New | +$13.9M |
|
420
Intuit
INTU
$88.5B
| $13.2M | 0.01% |
24,505
-700
| -3% | -$377K |
|
421
ACV Auctions
ACVA
$1.4B
| $13.2M | 0.01% |
736,762
+265,992
| +57% | +$5.65M |
|
422
Service Corp International
SCI
$11.7B
| $13M | 0.01% |
215,617
-35,360
| -14% | -$2.15M |
|
423
Lincoln Electric
LECO
$15.1B
| $12.9M | 0.01% |
99,860
-51,118
| -34% | -$6.95M |
|
|
NESR
424
National Energy Services Reunited Corp
NESR
$2.9B
| $12.8M | 0.01% |
1,024,784
+9,808
| +1% | +$119K |
|
425
Atlantic Union Bankshares
AUB
$6.16B
| $12.8M | 0.01% |
347,223
-1,872
| -0.5% | -$67.4K |
|
Similar funds
Jennison Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Jennison Associates held 761 positions worth $155B, up 2.5% from $151B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jennison Associates's Q3 2021 filing shows 96 new, 254 increased, 288 reduced and 100 closed positions. Its largest new stake was ZoomInfo Technologies: 3,206,107 shares worth $196M. The largest sale was Match Group, an estimated $929M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2021 buy was ZoomInfo Technologies: 3,206,107 shares worth $196M.
- Jennison Associates added most to BioNTech in Q3 2021, an estimated $1.21B increase.
- Jennison Associates's biggest Q3 2021 reduction was Match Group, cutting an estimated $929M.
- Jennison Associates fully exited Zoom in Q3 2021, selling an estimated $285M.
- Jennison Associates's ten largest holdings make up 38% of its $155B portfolio in Q3 2021.
- Jennison Associates opened 96 new positions and closed 100 in Q3 2021.
- Jennison Associates's portfolio value rose 2.5% quarter-over-quarter to $155B.
Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.